The emerging role of enhanced external counterpulsation in cardiovascular disease managementSTROBECK, J. E; BAKLAJIAN, R; HANNAN, J. C et al.Cardiovascular reviews & reports. 1997, Vol 18, Num 11, pp 20-25, issn 0197-3118Article

OPC-8212 in the treatment of congestive heart failure: results of a Pilot studyKUBO, S. H; RECTOR, T. S; STROBECK, J. E et al.Cardiovascular drugs and therapy. 1988, Vol 2, Num 5, pp 653-660Article

Effects of vesnarinone on morbidity and mortality in patients with heart failureFELDMAN, A. M; BRISTOW, M. R; WHITE, B. G et al.The New England journal of medicine. 1993, Vol 329, Num 3, pp 149-155, issn 0028-4793Article

Usrefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathyFELDMAN, A. M; BAUGHMAN, K. L; LEE, W. K et al.The American journal of cardiology. 1991, Vol 68, Num 11, pp 1203-1210, issn 0002-9149Article

Effects of experimental phosphate deficiency on action potential characteristics and contractile performance of rat myocardiumCAPASSO, J. M; ARONSON, R. S; STROBECK, J. E et al.Cardiovascular research. 1982, Vol 16, Num 2, pp 71-79, issn 0008-6363Article